Trial Profile
Radiotherapy concurrent with S-1 and radiotherapy alone for T2N0 glottic carcinoma: a retrospective comparative study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Laryngeal cancer
- Focus Adverse reactions; Therapeutic Use
- 21 Dec 2015 New trial record